Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications
N Terada, S Akamatsu, T Kobayashi… - … in medical oncology, 2017 - journals.sagepub.com
Advances in our understanding of the mechanisms driving castration-resistant prostate
cancer have promoted the development of several new drugs including androgen receptor …
cancer have promoted the development of several new drugs including androgen receptor …
Patient-derived xenografts as in vivo models for research in urological malignancies
T Inoue, N Terada, T Kobayashi, O Ogawa - Nature Reviews Urology, 2017 - nature.com
Lack of appropriate models that recapitulate the complexity and heterogeneity of urological
tumours precludes most of the preclinical reagents that target urological tumours from …
tumours precludes most of the preclinical reagents that target urological tumours from …
Pre-flight calibration and near-earth commissioning results of the mercury plasma particle experiment (MPPE) onboard MMO (Mio)
Y Saito, D Delcourt, M Hirahara, S Barabash… - Space Science …, 2021 - Springer
BepiColombo Mio (previously called MMO: Mercury Magnetospheric Orbiter) was
successfully launched by Ariane 5 from Kourou, French Guiana on October 20, 2018. The …
successfully launched by Ariane 5 from Kourou, French Guiana on October 20, 2018. The …
The natural history of simple renal cysts
N TERAdA, K Ichioka, Y Matsuta, K Okubo… - The Journal of …, 2002 - auajournals.org
Purpose: Although simple renal cysts are common in older patients, little is known
concerning their natural history. We examined the natural history of renal cysts by …
concerning their natural history. We examined the natural history of renal cysts by …
Loss of the Martian atmosphere to space: Present-day loss rates determined from MAVEN observations and integrated loss through time
Observations of the Mars upper atmosphere made from the Mars Atmosphere and Volatile
Evolution (MAVEN) spacecraft have been used to determine the loss rates of gas from the …
Evolution (MAVEN) spacecraft have been used to determine the loss rates of gas from the …
Prevalence of and risk factors for nocturia: analysis of a health screening program
K Yoshimura, N Terada, Y Matsui… - … journal of urology, 2004 - Wiley Online Library
Background: We examined the prevalence of and risk factors for nocturia in Kurashiki city
and the surrounding area, a rural area in Japan. Materials and Methods: We collected data …
and the surrounding area, a rural area in Japan. Materials and Methods: We collected data …
The 10-year natural history of simple renal cysts
N Terada, Y Arai, N Kinukawa, A Terai - Urology, 2008 - Elsevier
OBJECTIVE: We previously reported the natural history of renal cysts, with a mean follow-up
of 6 years. Here, we extended the follow-up period to 10 years. METHODS: From January …
of 6 years. Here, we extended the follow-up period to 10 years. METHODS: From January …
[HTML][HTML] Cancer/testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy
T Shiraishi, N Terada, Y Zeng, T Suyama, J Luo… - Journal of translational …, 2011 - Springer
Abstract Background The Cancer/Testis Antigens (CTAs) are an important group of proteins
that are typically restricted to the testis in the normal adult but are aberrantly expressed in …
that are typically restricted to the testis in the normal adult but are aberrantly expressed in …
[HTML][HTML] Martian moons exploration MMX: sample return mission to Phobos elucidating formation processes of habitable planets
K Kuramoto, Y Kawakatsu, M Fujimoto, A Araya… - Earth, Planets and …, 2022 - Springer
Martian moons exploration, MMX, is the new sample return mission planned by the Japan
Aerospace Exploration Agency (JAXA) targeting the two Martian moons with the scheduled …
Aerospace Exploration Agency (JAXA) targeting the two Martian moons with the scheduled …
Nocturia and benign prostatic hyperplasia
K Yoshimura, H Ohara, K Ichioka, N Terada, Y Matsui… - Urology, 2003 - Elsevier
OBJECTIVES: To examine the frequency of and risk factors for nocturia in patients with
symptomatic benign prostatic hyperplasia (BPH), and the degree of improvement of nocturia …
symptomatic benign prostatic hyperplasia (BPH), and the degree of improvement of nocturia …